Your browser doesn't support javascript.
loading
Bullous pemphigoid in diabetic patients treated by gliptins: the other side of the coin.
Chouchane, Karim; Di Zenzo, Giovanni; Pitocco, Dario; Calabrese, Laura; De Simone, Clara.
Affiliation
  • Chouchane K; Whittington Health NHS Trust, Magdala Ave, London, N19 5NF, UK. karim.chouchane@nhs.net.
  • Di Zenzo G; Molecular and Cell Biology Laboratory, Istituto Dermopatico dell'Immacolata (IDI) IRCCS, Rome, Italy.
  • Pitocco D; Diabetes Care Unit, Endocrinology, University Hospital "A. Gemelli", Catholic University of the Sacred Heart, Rome, Italy.
  • Calabrese L; Institute of Dermatology, University Hospital "A. Gemelli", Catholic University of the Sacred Heart, Rome, Italy.
  • De Simone C; Department of Dermatology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
J Transl Med ; 19(1): 520, 2021 12 20.
Article in En | MEDLINE | ID: mdl-34930319
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pemphigoid, Bullous / Diabetes Mellitus / Dipeptidyl-Peptidase IV Inhibitors Limits: Humans Language: En Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pemphigoid, Bullous / Diabetes Mellitus / Dipeptidyl-Peptidase IV Inhibitors Limits: Humans Language: En Year: 2021 Type: Article